Navigation Links
Does foreign policy help or hinder global health?
Date:4/20/2010

This week PLoS Medicine launches a series on Global Health Diplomacy with an introductory article outlining the intersection between foreign policy and global health interests, and a case study of Brazil's growing influence in international relations.

In the first article in the series, Harley Feldbaum and Joshua Michaud from the Johns Hopkins School of Advanced International Studies in Washington DC address how the public health community has "seized upon" the concept of health diplomacy to raise the profile of health in the practice of foreign policy, often uncritically. They observe that foreign policy priorities can often determine priority setting and funding for global health, reflected in recent times by the focus of certain governments on the threat of bioterrorism, risks of infectious disease like H1N1 influenza, and operations in Iraq and Afghanistan designed to "win hearts and minds."

Moreover, the authors argue, health interventions are sometimes used to further ulterior foreign policy objectives. For example, "countries are increasingly using health initiatives as a means to improve security, project power and influence, improve their international image, or support other traditional foreign policy objectives." For this reason, the authors conclude, public health advocates must engage with foreign policy interests with caution.

In the second article in the series, Kelley Lee from the London School of Hygiene & Tropical Medicine (LSHTM) and colleagues analyze the growing influence of Brazil in international relations and, in particular, its prominent role in negotiating the Framework Convention for Tobacco Control (FCTC). The authors report that Brazil has achieved this recognition by engaging in "soft power" a diplomatic approach based on persuasion and collaboration, rather than economic influence or political domination. In the FCTC negotiations, Brazil was instrumental by serving as an exemplar for domestic tobacco control, engaging in "coalition politics," and providing leadership throughout the negotiation process. This use of soft power in global tobacco control follows on from Brazil's prominence in the access to medicines debate, focused on upholding the country's constitutional guarantee of access to anti-retr oviral drugs for people living with HIV/AIDS and negotiating firmly to ensure access within World Trade Organization guidelines.

The PLoS Medicine series continues over the coming weeks with additional case studies examining SARS as a watershed for China's engagement in global health diplomacy, and the controversies surrounding avian influenza A (H5N1) and pandemic influenza A (H1N1) in potentially limiting equitable access to influenza vaccine. The PLoS Medicine series concludes on 11 May 2010 with commentary from high-level diplomats providing critical insights into the challenges of engaging in global health diplomacy.


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request
2. Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009
3. ACS Webinar features tips for finding and building a career in public policy and chemical industry
4. National Center for Policy Analysis and Salem Radio Network Deliver One Million Emails to Congress to Stop ObamaCare
5. Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net
6. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
7. Long Island Pediatric Group Announces Policy Changes That Will Help More New Yorkers
8. Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health
9. How can policymakers cope with ambiguity?
10. Health Plan Policy Rescission Won't Go Away, Says NAIRO
11. ACP Advocate blog cited as best health policy/ethics Weblog
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... WhoHaha , a digital media company dedicated to creating and delivering female-centric, comedic content, ... series that uses humor to highlight ways to improve heart health and overall well-being. ... movement, which is designed to inspire all Americans to make small changes that add ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for patients with sleep apnea and TMJ disorders. These conditions are quite common ... Dr. Rassouli provides personalized care to reduce the risk of these consequences and ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative ... Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries from ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor ... global anti-obesity drugs market is expected to grow at a ... and CAGR of 38.7% in the second half of the forecast ... 32.8% from 2016 to 2027. The market is estimated at $1,058 ... 2027. ...
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
Breaking Medicine Technology: